PMC:7054527 / 5985-6364 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"226","span":{"begin":33,"end":37},"obj":"Gene"},{"id":"227","span":{"begin":123,"end":127},"obj":"Gene"},{"id":"228","span":{"begin":202,"end":209},"obj":"Gene"},{"id":"229","span":{"begin":286,"end":293},"obj":"Gene"},{"id":"246","span":{"begin":42,"end":51},"obj":"Species"},{"id":"247","span":{"begin":157,"end":166},"obj":"Species"},{"id":"248","span":{"begin":255,"end":264},"obj":"Species"},{"id":"250","span":{"begin":186,"end":192},"obj":"Chemical"}],"attributes":[{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"Gene:59272"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"Gene:59272"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"Gene:7113"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"Gene:7113"},{"id":"A246","pred":"tao:has_database_id","subj":"246","obj":"Tax:2697049"},{"id":"A247","pred":"tao:has_database_id","subj":"247","obj":"Tax:2697049"},{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"Tax:2697049"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"MESH:D012694"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"36–39. The high affinity between ACE2 and 2019-nCoV S protein also suggested that the population with higher expression of ACE2 might be more susceptible to 2019-nCoV40,41. The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36.\n\nThe possible transmission routes of"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":54,"end":61},"obj":"Body_part"},{"id":"T35","span":{"begin":186,"end":192},"obj":"Body_part"},{"id":"T36","span":{"begin":236,"end":243},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma82764"},{"id":"A36","pred":"fma_id","subj":"T36","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"36–39. The high affinity between ACE2 and 2019-nCoV S protein also suggested that the population with higher expression of ACE2 might be more susceptible to 2019-nCoV40,41. The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36.\n\nThe possible transmission routes of"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T55","span":{"begin":321,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"36–39. The high affinity between ACE2 and 2019-nCoV S protein also suggested that the population with higher expression of ACE2 might be more susceptible to 2019-nCoV40,41. The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36.\n\nThe possible transmission routes of"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":54,"end":61},"obj":"Chemical"},{"id":"T16","span":{"begin":186,"end":192},"obj":"Chemical"},{"id":"T17","span":{"begin":236,"end":243},"obj":"Chemical"},{"id":"T18","span":{"begin":294,"end":303},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_17822"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"36–39. The high affinity between ACE2 and 2019-nCoV S protein also suggested that the population with higher expression of ACE2 might be more susceptible to 2019-nCoV40,41. The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36.\n\nThe possible transmission routes of"}

{"project":"LitCovid-sentences","denotations":[{"id":"T38","span":{"begin":7,"end":172},"obj":"Sentence"},{"id":"T39","span":{"begin":173,"end":342},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"36–39. The high affinity between ACE2 and 2019-nCoV S protein also suggested that the population with higher expression of ACE2 might be more susceptible to 2019-nCoV40,41. The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36.\n\nThe possible transmission routes of"}

{"project":"2_test","denotations":[{"id":"32127517-32065055-53455639","span":{"begin":0,"end":2},"obj":"32065055"},{"id":"T24045","span":{"begin":0,"end":2},"obj":"32065055"}],"text":"36–39. The high affinity between ACE2 and 2019-nCoV S protein also suggested that the population with higher expression of ACE2 might be more susceptible to 2019-nCoV40,41. The cellular serine protease TMPRSS2 also contributed to the S-protein priming of 2019-nCoV, indicating that the TMPRSS2 inhibitor might constitute a treatment option36.\n\nThe possible transmission routes of"}